Blood Biomarkers for Traumatic Brain Injury: A Quantitative Assessment of Diagnostic and Prognostic Accuracy
Year: 2019
Type: review
Study designs: Systematic Review, Meta-Analysis
Abstract: Blood biomarkers have been explored for their potential to provide objective measures in the assessment of traumatic brain injury (TBI). However, it is not clear which biomarkers are best for diagnosis and prognosis in different severities of TBI. Here, we compare existing studies on the discriminative abilities of serum biomarkers for four commonly studied clinical situations: detecting concussion, predicting intracranial damage after mild TBI (mTBI), predicting delayed recovery after mTBI, and predicting adverse outcome after severe TBI (sTBI). We conducted a literature search of publications on biomarkers in TBI published up until July 2018. Operating characteristics were pooled for each biomarker for comparison. For detecting concussion, 4 biomarker panels and creatine kinase B type had excellent discriminative ability. For detecting intracranial injury and the need for a head CT scan after mTBI, 2 biomarker panels, and hyperphosphorylated tau had excellent operating characteristics. For predicting delayed recovery after mTBI, top candidates included calpain-derived αII-spectrin N-terminal fragment, tau A, neurofilament light, and ghrelin. For predicting adverse outcome following sTBI, no biomarker had excellent performance, but several had good performance, including markers of coagulation and inflammation, structural proteins in the brain, and proteins involved in homeostasis. The highest-performing biomarkers in each of these categories may provide insight into the pathophysiologies underlying mild and severe TBI. With further study, these biomarkers have the potential to be used alongside clinical and radiological data to improve TBI diagnostics, prognostics, and evidence-based medical management.
Source: Frontiers in Neurology
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Keywords: traumatic brain injury, blood biomarkers, serum biomarkers, concussion, mild traumatic brain injury, severe traumatic brain injury, prognostic factors, diagnostic accuracy, hyperphosphorylated tau, creatine kinase B, neurofilament light chain, ghrelin, delayed recovery, adverse outcome prediction, coagulation markers, inflammatory markers
Open Access status: gold
Estimated APC paid: $2,950
OpenAlex ID: W2940677715
